Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Labriola

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Bollettino Della Societa Italiana Di Cardiologia|January 1, 1978
[Nifedipine in the treatment of hypertensive crises]M G Marlettini, E Labriola, M De Novellis, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1991
Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptorE Labriola-Tompkins, C Chandran, K L Kaffka, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesisG Ju, E Labriola-Tompkins, C A Campen, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Bollettino Della Societa Italiana Di Cardiologia|January 1, 1978
[Nifedipine in the treatment of hypertensive crises]M G Marlettini, E Labriola, M De Novellis, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1991
Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptorE Labriola-Tompkins, C Chandran, K L Kaffka, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesisG Ju, E Labriola-Tompkins, C A Campen, et al.
Pageof 6